Page last updated: 2024-11-08

zn(ii)-phthalocyanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID518924
CHEBI ID51218
MeSH IDM0148156

Synonyms (28)

Synonym
ciaftalan zinc
[29h,31h-phthalocyaninato(2-)-kappa(4)n(29),n(30),n(31),n(32)]zinc
CHEBI:51218 ,
ciaftalanum zincum
(sp-4-1)-(phthalocyaninato(2-)-n(29),n(30),n(31),n(32))zinc
ciaftalane zinc
zinc phthalocyanine
phthalocyanine zinc
14320-04-8
(sp-4-1)-(phthalocyaninato(2-)-n(sup 29),n(sup 30),n(sup 31),n(sup 32))zinc
zinc, (29h,31h-phthalocyaninato(2-)-n29,n39,n31,n32)-, (sp-4-1)-
zinc, (29h,31h-phthalocyaninato(2-)-kappan29,kappan30,kappan31,kappan32)-, (sp-4-1)-
(29h,31h-phthalocyaninato(2-)-n29,n30,n31,n32)zinc
einecs 238-262-5
zn(ii)-phthalocyanine
unii-243kj527mc
ciaftalan zinc [inn]
243kj527mc ,
cgp-55,847
zinc(ii) phthalocyanine
ec 238-262-5
zn-phthalocyanine
cgp 55 847
PODBBOVVOGJETB-UHFFFAOYSA-N
zinc,[29h,31h-phthalocyaninato(2(-))-n<29>,n<30>,n<31>,n<32>]-(sp-4-1)-
zinc, [29h,31h-phthalocyaninato(2-)-n(29)-,n(30)-,n(31)-,n(32)-]-, (sp-4-1)-
CS-0014946
HY-19204

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"Comparative pharmacokinetic studies in hamsters bearing an induced or first-generation transplanted rhabdomyosarcoma that were injected with liposome-incorporated zinc(II) phthalocyanine (ZnPc) show a higher drug concentration in the induced tumour."( Comparative pharmacokinetic and photodynamic studies with zinc(II) phthalocyanine in hamsters bearing an induced or transplanted rhabdomyosarcoma.
Hadjiolov, D; Jori, G; Krastev, K; Mantareva, V; Milev, A; Ricchelli, F; Shopova, M; Spirov, K, 1992
)
0.28
" Both in vitro techniques gave similar results which are consistent with previous findings on the pharmacokinetic behavior of ZnPc."( A comparison of fluorescence methods used in the pharmacokinetic studies of Zn(II)phthalocyanine in mice.
Biolo, R; Jori, G; Kennedy, JC; Nadeau, P; Pottier, R; Reddi, E; Weagle, G, 1991
)
0.28
" When this technique is applied to mice that have been fed on a normal chlorophyll-based diet, and particularly when measurements are performed in the abdominal region, oscillations are sometimes observed superimposed on the pharmacokinetic curve of the ZnPc."( On the source of the oscillations observed during in vivo zinc phthalocyanine fluorescence pharmacokinetic measurements in mice.
Gudgin Dickson, EF; Holmes, H; Jori, G; Kennedy, JC; Nadeau, P; Pottier, RH; Rossi, F; Russell, DA; Weagle, GE, 1995
)
0.29

Compound-Compound Interactions

ExcerptReferenceRelevance
"Chemotherapy is a generally used anticancer strategy for melanoma and it may have improved outcomes in combination with other approaches."( Photodynamic therapy using zinc phthalocyanine with low dose of diode laser combined with doxorubicin is a synergistic combination therapy for human SK-MEL-3 melanoma cells.
Baghbani, E; Baradaran, B; Doustvandi, MA; Hajiasgharzadeh, K; Hamblin, MR; Khaze, V; Mansoori, B; Moghaddam, MM; Mohammadi, A; Mohammadnejad, F; Mokhtarzadeh, A; Tajalli, H, 2019
)
0.51

Bioavailability

ExcerptReferenceRelevance
" By encapsulation into micellar nanoparticles, the bioavailability of PC(Zn) increased significantly, enabling smart photodynamic therapy for future applications in cancer-related diseases."( Double stimuli-responsive polysaccharide block copolymers as green macrosurfactants for near-infrared photodynamic therapy.
Breitenbach, BB; Konhäuser, M; Parekh, SH; Steiert, E; Vogt, LM; Wang, Y; Wich, PR, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Tumors were removed 3 h or 24 h after dosing the intratumoral distribution determined by fluorescence microscopy."( Liposome-mediated delivery of photosensitizers: localization of zinc (II)-phthalocyanine within implanted tumors after intravenous administration.
Biolo, R; Duk, S; Jori, G; Love, WG; Taylor, PW, 1996
)
0.29
" A dose-response phototoxic effect with both phthalocyanines was observed."( Photodynamic activity of aluminium (III) and zinc (II) phthalocyanines in Leishmania promastigotes.
Escobar, P; Hernández, IP; Martínez, F; Páez, E; Rueda, CM, 2006
)
0.33
"Within the power densities 36-144J/cm(2), the irradiation dose showed a significant dose-response relationship; under the same drug dosage, an increase in irradiation dose could enhance the inhibitory effect on tumor growth."( Optimal light dose and drug dosage in the photodynamic treatment using PHOTOCYANINE.
Chen, N; Huang, J; Li, C; Liu, H; Wei, J; Xue, J, 2011
)
0.37
" How to obtain the high efficiency of singlet oxygen generation under low 980 nm radiation dosage still remains a challenge."( An upconversion nanoparticle--Zinc phthalocyanine based nanophotosensitizer for photodynamic therapy.
Chang, Y; Kong, X; Liu, K; Liu, X; Shen, D; Tu, L; Xia, L; Zhang, H; Zhang, Y; Zhao, H, 2014
)
0.4
" Fluorescence images of skin samples after 24h of permeation were in line with ZnPc dosage in the skin and demonstrated the ability of NPs covalently tagged with rhodamine to penetrate the skin and to locate in the intercellular spaces."( Skin transport of PEGylated poly(ε-caprolactone) nanoparticles assisted by (2-hydroxypropyl)-β-cyclodextrin.
Conte, C; Costabile, G; d'Angelo, I; Grassia, G; Ialenti, A; Miro, A; Musto, P; Pannico, M; Quaglia, F; Tirino, P; Ungaro, F, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
zinc tetrapyrrole
metallophthalocyanine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (440)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (0.91)18.7374
1990's56 (12.73)18.2507
2000's74 (16.82)29.6817
2010's231 (52.50)24.3611
2020's75 (17.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.81 (24.57)
Research Supply Index6.10 (2.92)
Research Growth Index5.91 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.45%)5.53%
Reviews7 (1.57%)6.00%
Case Studies1 (0.22%)4.05%
Observational0 (0.00%)0.25%
Other435 (97.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]